{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:11:28Z","timestamp":1793059888265,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.diabet.2022.101395","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T09:06:39Z","timestamp":1664442399000},"page":"101395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["1-h post-load plasma glucose for detecting early stages of prediabetes"],"prefix":"10.1016","volume":"48","author":[{"given":"M.","family":"Buysschaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Valensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.diabet.2022.101395_bib0001","first-page":"S17","article-title":"American Diabetes Association Professional Practice Committee. Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0002","unstructured":"World Health Organization. https:\/\/www.who.int\/diabetes\/publications\/diagnosis_diabetes2006\/en\/index.html"},{"key":"10.1016\/j.diabet.2022.101395_bib0003","unstructured":"International Diabetes Federation Atlas, 10th edition, 2021"},{"key":"10.1016\/j.diabet.2022.101395_bib0004","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2022.101395_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12020-014-0436-2","article-title":"Prediabetes and associated disorders","volume":"48","author":"Buysschaert","year":"2015","journal-title":"Endocrine"},{"issue":"Suppl 1","key":"10.1016\/j.diabet.2022.101395_bib0006","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1055\/s-0029-1240928","article-title":"A European evidence-based guideline for the prevention of type 2 diabetes","volume":"42","author":"Paulweber","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabet.2022.101395_bib0007","doi-asserted-by":"crossref","first-page":"i5953","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all-cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2022.101395_bib0008","doi-asserted-by":"crossref","first-page":"m2297","DOI":"10.1136\/bmj.m2297","article-title":"Association between prediabetes and risk of all-cause mortality and cardiovascular disease: updated meta-analysis","volume":"370","author":"Cai","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2022.101395_bib0009","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00125-008-1246-y","article-title":"Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study","volume":"52","author":"Barr","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2022.101395_bib0010","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2009.10.060","article-title":"Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence","volume":"55","author":"Ford","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabet.2022.101395_bib0011","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2022.101395_bib0012","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","article-title":"Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study","volume":"359","author":"Norhammar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2022.101395_bib0013","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.amjcard.2005.03.076","article-title":"Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome","volume":"96","author":"Conaway","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabet.2022.101395_bib0014","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ehj.2004.07.027","article-title":"Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart","volume":"25","author":"Bartnik","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabet.2022.101395_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-015-0296-y","article-title":"Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the Euro Observational Research Programme of the European Society of Cardiology","volume":"14","author":"Gyberg","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2022.101395_bib0016","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1475-2840-11-78","article-title":"The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively","volume":"11","author":"Mazurek","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2022.101395_bib0017","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/eurjhf\/hfq216","article-title":"Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis","volume":"13","author":"Egstrup","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.diabet.2022.101395_bib0018","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ejhf.2403","article-title":"PARAGON-HF Committees and Investigators. Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction","volume":"24","author":"Jackson","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.diabet.2022.101395_bib0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12933-022-01509-5","article-title":"Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension","volume":"21","author":"Son","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2022.101395_bib0020","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/dme.13113","article-title":"Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis","volume":"33","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2022.101395_bib0021","doi-asserted-by":"crossref","first-page":"e1772","DOI":"10.1210\/clinem\/dgaa017","article-title":"Association of prediabetes with CKD progression and adverse cardiovascular outcomes: an analysis of the CRIC study","volume":"105","author":"Neves","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101395_bib0022","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1464-5491.2007.02043.x","article-title":"The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program","volume":"24","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2022.101395_bib0023","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2337\/dc14-2585","article-title":"Peripheral neuropathy and nerve dysfunction in individuals at high risk for type 2 diabetes: the PROMISE Cohort","volume":"38","author":"Lee","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0024","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1464-5491.2010.03222.x","article-title":"Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study","volume":"28","author":"Valensi","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2022.101395_bib0025","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","article-title":"Type 2 Diabetes and Cancer: an umbrella review of observational and mendelian randomization studies","volume":"30","author":"Pearson-Stuttard","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.diabet.2022.101395_bib0026","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Diabetes Prevention Program Research. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"Perreault","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2022.101395_bib0027","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2022.101395_bib0028","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Da Qing Diabetes Prevention Study Group. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2022.101395_bib0029","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2337\/diacare.21.10.1720","volume":"21","author":"Chiasson","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0030","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCULATIONAHA.121.056756","article-title":"Diabetes prevention program research group. effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study","volume":"145","author":"Goldberg","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.diabet.2022.101395_bib0031","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2337\/dc21-1046","article-title":"Diabetes Prevention Program Research Group; Diabetes Prevention Program Research Group. Effect of metformin and lifestyle interventions on mortality in the diabetes prevention program and diabetes prevention program outcomes study","volume":"44","author":"Lee","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1573399811666150122150233","article-title":"Definitions (and current controversies) of diabetes and prediabetes","volume":"12","author":"Buysschaert","year":"2016","journal-title":"Curr Diabetes Rev"},{"issue":"5","key":"10.1016\/j.diabet.2022.101395_bib0033","first-page":"19","article-title":"The 1-h post-load plasma glucose as a novel biomarker for diagnosing dysglycemia","volume":"55","author":"Jagannathan","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabet.2022.101395_bib0034","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41574-022-00670-x","article-title":"Remission of T2DM requires early diagnosis and substantial weight reduction","volume":"18","author":"Bergman","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabet.2022.101395_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108233","article-title":"Review of methods for detecting glycemic disorders","volume":"165","author":"Bergman","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2022.101395_bib0036","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2337\/diacare.21.3.336","article-title":"Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75\u00a0g oral glucose","volume":"21","author":"Wolever","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0037","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1016\/j.numecd.2021.06.017","article-title":"Acute and long-term effects of saxagliptin on a set of cardiovascular targets measured at fasting and post-prandially in obese patients with impaired glucose toleraernce: a placebo-controlled study","volume":"31","author":"Rezki","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabet.2022.101395_bib0038","doi-asserted-by":"crossref","first-page":"e2992","DOI":"10.1002\/dmrr.2992","article-title":"Lessons learned from the 1-hour post-load glucose level during OGTT: current screening recommendations for dysglycaemia should be revised","volume":"34","author":"Bergman","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2022.101395_bib0039","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12020-017-1236-2","article-title":"Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1\u2009h post-load glucose levels?","volume":"55","author":"Bergman","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.diabet.2022.101395_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000837","article-title":"Metabolic characteristics of Africans with normal glucose tolerance and elevated 1-hour glucose: insight from the Africans in America study","volume":"8","author":"Briker","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0041","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.metabol.2006.08.024","article-title":"Predicting more accurately the overall glucose response to a lunch meal by using the postprandial glucose peak","volume":"56","author":"Chapelot","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2022.101395_bib0042","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","article-title":"One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes","volume":"31","author":"Abdul-Ghani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0043","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-014-3390-x","article-title":"Modelling of OGTT curve identifies 1h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts","volume":"58","author":"Alyass","year":"2015","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.diabet.2022.101395_bib0044","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00592-015-0829-6","article-title":"The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia","volume":"53","author":"Jagannathan","year":"2016","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.diabet.2022.101395_bib0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2018-01828","article-title":"1-Hour Post-OGTT Glucose Improves the Early Prediction of Type 2 Diabetes by Clinical and Metabolic Markers","volume":"104","author":"Peddinti","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101395_bib0046","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1210\/clinem\/dgaa372","article-title":"Pitfalls of HbA1c in the Diagnosis of Diabetes","volume":"105","author":"Bergman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101395_bib0047","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/dc06-1612","article-title":"The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes","volume":"30","author":"Monnier","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0048","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1210\/jc.2018-00468","article-title":"One-Hour Postload Hyperglycemia: implications for Prediction and Prevention of Type 2 Diabetes","volume":"103","author":"Fiorentino","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101395_bib0049","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/dc17-1351","article-title":"Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: a Prospective Population-Based Cohort Study","volume":"41","author":"Pareek","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2022.101395_bib0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/dia.2013.0025","article-title":"1-hour venous plasma glucose and incident prediabetes and diabetes in Asian indians","volume":"15","author":"Priya","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2022.101395_bib0051","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1210\/jc.2015-2573","article-title":"One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose","volume":"100","author":"Fiorentino","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101395_bib0052","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diabres.2016.08.013","article-title":"One-hour post-load plasma glucose level during the OGTT predicts dysglycemia: observations from the 24year follow-up of the Israel Study of Glucose Intolerance, Obesity and Hypertension","volume":"120","author":"Bergman","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2022.101395_bib0053","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cen.13280","article-title":"One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study","volume":"86","author":"Oh","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.diabet.2022.101395_bib0054","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jdiacomp.2017.07.017","article-title":"The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects","volume":"31","author":"Sai Prasanna","year":"2017","journal-title":"J Diabetes Complic"},{"key":"10.1016\/j.diabet.2022.101395_bib0055","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/dme.13116","article-title":"One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension","volume":"33","author":"Bergman","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2022.101395_bib0056","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.diabres.2018.09.017","article-title":"Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose\u00a0\u2265\u00a0155\u00a0mg\/dl (8.6\u00a0mmol\/L)","volume":"146","author":"Bergman","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2022.101395_bib0057","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/dc20-1688","article-title":"Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: a meta-analysis","volume":"44","author":"Ahuja","year":"2021","journal-title":"Diabetes Care"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363622000775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363622000775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:00:07Z","timestamp":1761130807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363622000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1262363622000775"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2022.101395","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-h post-load plasma glucose for detecting early stages of prediabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2022.101395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101395"}}